Preprint · September 18, 2025
Obesity is a worsening global epidemic that is regulated by the microbiota through unknown bacterial factors. We discovered a human commensal bacterium, Clostridium immunis , that treats obesity by secreting a phosphocholine-modified exopolysaccharide. Los ...
Full textLink to itemCite
Journal articleCell Rep · August 29, 2023
Little is known about how microbiota regulate innate-like γδ T cells or how these restrict their effector functions within mucosal barriers, where microbiota provide chronic stimulation. Here, we show that microbiota-mediated regulation of γδ17 cells is bi ...
Full textLink to itemCite
Journal articleClin Infect Dis · December 20, 2021
BACKGROUND: Enterococcus intestinal domination (EID), a state of dysbiosis wherein enterococci comprise ≥30% abundance within the microbiota, has been associated with Enterococcus bacteremia, graft-versus-host disease, and mortality in the allogeneic hemat ...
Full textLink to itemCite
Journal articleJ Immunol · October 1, 2021
The microbiota-the diverse set of commensal microbes that normally colonize humans-represents the first line of defense against infectious diseases. In this review, we summarize the direct and indirect mechanisms by which the microbiota modulates susceptib ...
Full textLink to itemCite
Journal articleProceedings of the National Academy of Sciences of the United States of America · November 2020
Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, has resulted thus far in greater than 933,000 deaths worldwide; yet disease pathogenesis remains unclear. Clinical and immunological features of patients with COVID-19 have high ...
Full textCite
Journal articleJ Virol · December 1, 2019
The hepatitis C virus (HCV) NS3-NS4A protease complex is required for viral replication and is the major viral innate immune evasion factor. NS3-NS4A evades antiviral innate immunity by inactivating several proteins, including MAVS, the signaling adaptor f ...
Full textLink to itemCite
Journal articlePLoS One · 2018
Cancer cells, including in chronic myeloid leukemia (CML), depend on the hypoxic response to persist in hosts and evade therapy. Accordingly, there is significant interest in drugging cancer-specific hypoxic responses. However, a major challenge in leukemi ...
Full textLink to itemCite